NDC product
Phentermine Hydrochloride
NDC 84053-910 · Martek Pharmacal Co.
Key facts
| Product NDC | 84053-910 |
|---|---|
| Proprietary name | Phentermine Hydrochloride |
| Nonproprietary name | Phentermine Hydrochloride |
| Substances | PHENTERMINE HYDROCHLORIDE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | Martek Pharmacal Co. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA202248 |
| DEA schedule | CIV |
| Pharmacologic classes | Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC] |
| Marketing start | Feb 12, 2024 |
| Marketing end | Apr 29, 2028 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory